EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease

Saima Shakil Malik iD, Xinchun Pi, Liang Xie

International Journal of Molecular Sciences · 22.05.2026 · 27 (11) · 4662

DOI: 10.3390/ijms27114662 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2026. Verfasst von Saima Shakil Malik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Protein Processing, Post-Translational, N-Acetylglucosaminyltransferases, Acetylglucosamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O-GlcNAcylation is a ubiquitous post-translational modification regulated by O-GlcNAcase (OGA) and O-GlcNAc transferase (OGT) in response to environmental and genetic alterations. It occurs in the nucleus, mitochondrion, and cytoplasm and is implicated in cardiovascular disease (CVD) development. O-GlcNAcylation modulates diverse cellular processes, including metabolic pathways, signaling networks, and transcriptional programs. Acute increase in O-GlcNAcylation serves as an adaptive response that preserves cardiac function, whereas chronic elevation leads to persistent metabolic dysregulation and promotes pathological cardiac remodeling. In this review, we provide a comprehensive overview of the role of O-GlcNAcylation across diverse disease contexts. We also summarize the current understanding of its complex interplay with CVD, including the underlying mechanisms. Finally, we highlight existing knowledge gaps and discuss the therapeutic potential of targeting O-GlcNAcylation in various cardiovascular events, emphasizing key priorities for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesProtein Processing, Post-TranslationalN-AcetylglucosaminyltransferasesAcetylglucosamineCardiovascular Physiological PhenomenaHumansAnimalsGlycosylationSignal Transductionbeta-N-Acetylhexosaminidases

Stichwörter der Autor:innen

O-GlcNAcylationcardiovascular diseaseglycosylationheart failure

Substanzen

N-AcetylglucosaminyltransferasesO-GlcNAc transferaseAcetylglucosaminebeta-N-Acetylhexosaminidases

Autor:innen und Institutionen

  • Department of Medicine, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID-Profile: Saima Shakil Malik

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Malik, S. S., Pi, X., & Xie, L. (2026). O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease. International Journal of Molecular Sciences, 27(11), 4662. https://doi.org/10.3390/ijms27114662

Vancouver

Malik SS, Pi X, Xie L. O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease. International Journal of Molecular Sciences. 2026;27(11):4662. doi:10.3390/ijms27114662

BibTeX
@article{Malik2026,
  author = {Malik, Saima Shakil and Pi, Xinchun and Xie, Liang},
  title = {O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {4662},
  doi = {10.3390/ijms27114662}
}
Kostenlos starten →